Efficacy of Mezigdomide Plus Dexamethasone and Bortezomib or Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma by Line of Therapy: Results from the Phase 1/2 CC-92480-MM-002 Trial
作者
Albert Oriol,Paul Gerard Guy Richardson,Marc Steffen Raab,Darrell J. White,Richard LeBlanc,Noopur S Raje,Enrique M. Ocio,Aurore Perrot,Thierry T.F. Facon,Cesar Rodriguez Valdes,Ralph Wäsch,Meletios Athanasios Dimopoulos,Jing Gong,Shudi Li,Tiziana Civardi,Phillip Koo,Erica Petrlik,Jessica B. Katz,Irwindeep Sandhu